banning tirzepatide WADA just added (mounjaro) to the 2026 Monitoring Program Lilly's weight-loss drug removed from

In preclinical animal models, it is known that variations in blood or brain glucose concentrations affect baseline nociceptive processing and opioid antinociception [10,11]

If you want to eat as much as possible, don't want to hit the gym, and still want to lose weight, it might seem like science fiction, but it's not

[DOI] [PubMed] [Google Scholar] 93.El-Mallakh RS, Vhringer PA, Ostacher MM, Baldassano CF, Holtzman NS, Whitham EA, et al

Because of obesity being considered a chronic disease, they need to take the treatment indefinitely or risk regaining weight, experts say

For symptom management of neuropathic pain, the American Academy of Neurology and American Diabetes Association guidelines recommend: First-line: Duloxetine or pregabalin (with appropriate renal dose adjustments) Alternative options: Gabapentin (with renal dose adjustments) or tricyclic antidepressants (with caution in older adults and cardiac disease) Topical treatments: Capsaicin 8% patch or lidocaine 5% patch for localized symptoms Avoid chronic opioid therapy due to limited evidence and safety concerns Non-pharmacological approaches including physical therapy, proper foot care, and pain psychology techniques provide additional benefit

This mix might not be suitable for people with low fasting glucose levels or those taking insulin or sulfonylureas